Surface Guided Radiation Therapy (SGRT) Devices Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2021 to 2028

Description

Surface Guided Radiation Therapy (SGRT) Devices Market size valued USD x billion in 2021 and is expected to reach USD x billion by 2028, growing at a CAGR of x% during the forecast period 2022-2028. Surface guided radiation therapy (SGRT) uses technology to position and monitor the patient’s external surface in order to ensure that they are in correct position throughout their radiation treatment. It provides transitional and rotational information of the patient’s skin surface and offers the potential to improve the accuracy of setup. The surface guided radiation therapy (SGRT) is used in both setup and therapy for breast, deep inspiration breath-hold (DIBH), head and neck, pediatrics and other indications. It is a rapidly growing technique that uses stereo vision technology to track patients’ surface in 3D during radiotherapy.  This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. The major market participants are adopting the strategies such as mergers and acquisitions to position themselves as strong players. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply.

Key Developments:

In March 2022, C-RAD has made agreement to supply its cutting-edge SGRT solution to a newly built proton therapy center in Texas, US. The agreement includes multiple systems and a multiyear service agreement.

In October 2021, Vision RT introduced its latest product, DoseRT™, showcased at last year’s ASTRO Annual Meeting. As the pioneer of SGRT, Vision RT now brings another world’s first – real-time patient monitoring and beam imaging, at the same time. DoseRT is born from combining the power of Cherenkov Imaging with BeamSite™ (DoseOptics LLC) and Vision RT’s newest camera system, Horizon.